Young Black Adults Experienced Rising Burden of CVD Risk Factors, Worse Hospital Outcomes in 10-year Study
AHA Scientific Sessions 2021: National study of over 2.9 million young Black adults showed increased rates of CVD risk factors and worsened hospital outcomes between 2007 and 2017.
Prioritizing Mental Health: Applying Person-First Approaches to Care
When addressing mental health with patients with obesity, a thoughtful approach that balances psychological health and weight loss is critical, explains Dr Ethan Lazarus.
Study: Hispanic Adults, Women, and Older E-cigarette Users Face Higher Odds of Asthma and COPD
CHEST 2021: Study shows vaping raises the odds of developing asthma and COPD, especially in older adults, women, and Hispanic persons.
Dupilumab Associated with Reduced Oral Corticosteroids in Severe Asthma, Regardless of Baseline OCS Dose
In patients with severe asthma dependent on OCS, dupilumab reduced OCS dose and improved the odds of no longer requiring OCS, suggests research presented at CHEST 2021.
Tezepelumab May Improve Peak Expiratory Flow in Patients with Severe Asthma, Suggests Analysis of NAVIGATOR Trial
CHEST 2021: Patients with severe asthma who received tezepelumab compared with placebo demonstrated rapid improvement in morning and evening peak expiratory flow.
Janssen RSV Vaccine for Older Adults Drives Robust Cellular Immune, Humoral Response
Janssen's investigational vaccine showed efficacy of up to 80% in preventing RSV-mediated lower respiratory tract infections in older adults.
Black Women with HIV at Highest Risk for Premature Mortality a 21-year Study Finds
IDWeek 2021: Despite declining mortality rates among patients with HIV in the past 2 decades, a new study finds significant disparities in gender and race.
People Living with HIV Use Fewer Essential Clinical Services and Less Frequently During Pandemic
Viral-load monitoring rates decreased and clinic visits declined overall despite an increase in use of telehealth.
CDI-specific Follow-up Visits Rare among Patients Hospitalized for Recurrence
IDWeek 2021: A new study found that only 16% of patients with CDI rehospitalized for recurrent infection had been seen in follow-up 30 days after original discharge.
Health Care Workers Likely to Recommend COVID-19 Vaccine to Patients Based on Safety Messaging, Survey Finds
Survey authors said findings merit further research into how to increase health care workers' confidence in discussing and recommending COVID-19 vaccines with patients.
Obesity May Put Children Hospitalized with COVID-19 at Higher Risk for Severe Disease, Suggests New Study
IDWeek 2021: Obesity prevention and vaccination efforts may help prevent COVID-19-related morbidity in pediatric COVID-19 patients with obesity, noted authors of a new study.
IDWeek 2021: C diff Clinical Outcomes Unchanged after 2017 IDSA Guideline Update
IDWeek 2021: Use of vancomycin vs metronidazole increased after the 2017 IDSA recommendation but CDI recurrence rates increased slightly, investigators report.
HCV Cure is Possible in Young Drug Users, Suggests New Research Being Presented at IDWeek 2021
IDWeek 2021: Young people who inject drugs can be cured of hepatitis C virus infection, according to 2 new studies.
Remdesivir May Significantly Reduce Risk of Hospitalization in High-risk COVID-19 Patients, Suggests New Study
Findings from a phase 3 clinical trial showed remdesivir reduced the risk of COVID-19-related hospitalizations by 87% in high-risk patients, the drug's manufacturer announced.
At ADA 2021, John Buse, MD, PhD, says US Must Focus on Control of Obesity, Other T2D Risk Factors
Diabetes investigator John Buse, MD, PhD, says laser focus on reducing T2D risk factors is equally as important as using the next right drug against the disease.
Inside GRADE: Exec Committee Member John Buse, MD, PhD, Toplines Study Results, Calls for More Head-to-Head Research
Dr Buse’s in-depth review of the GRADE study is followed by a discussion of the keen need for more comparative research and the many new questions the results have raised about optimal T2D therapy.
ADA 2021: Baseline Insulin Use May not Impact Benefits of Finerenone in Patients with CKD, T2D
ADA 2021. A subgroup analysis of the FIDELIO-DKD trial showed that finerenone use was beneficial regardless of baseline insulin use among patients with T2D and CKD.
GLP-1 RA, Insulin More Effective Second-line vs Sulfonylurea, DPP-4 Inhibitor for T2D
Preliminary GRADE study results showed that liraglutide and insulin glargine added to metformin maintained A1c level in target range longer than glimepiride or sitagliptin.
ADA 2021: Use of Dapagliflozin Decreases Risk of Diabetes in Patients with CKD
ADA 2021. Dapagliflozin was found to reduce type 2 diabetes incidence among patients with chronic kidney disease in a prespecified analysis of the DAPA-CKD trial.
ADA 2021: Renoprotection with Finerenone Consistent Regardless of SGLT2 Inhibitor Use
ADA 2021. A prespecified subanalysis of FIDELIO-DKD found primary and secondary renal and CV endpoints consistent whether or not SGLT2 inhibitors were on board at study baseline.
